Gamma-Dynacare introduces fecal immunochemical test for colorectal cancer screening

Gamma-Dynacare Medical Laboratories now offers two advanced screening tests for colorectal cancer. Gamma- Dynacare’s fecal immunochemical test (FIT) is a non-invasive test that checks for occult blood in stool using advanced immunochemical technology. Polyps or tumors in the colon have blood vessels on their surface that can release a small amount of blood into the stool. FIT helps identify benign polyps early before they become cancerous. With this technology, FIT has a higher sensitivity than the traditional fecal occult blood test, has no dietary or medicinal restrictions, and requires only one stool sample. Gamma- Dynacare’s other colorectal screening test, Septin9, detects the presence of methylated Septin9 DNA in blood, which has been strongly correlated with an increased risk of colorectal cancer. The test is very convenient since it is performed on a blood sample and has no dietary or medicinal restrictions. For more information on these tests, visit www.gamma-dynacare.com.